Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 17, 2002Alimentary Pharmacology & Therapeutics

Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients

View Full Paper
Ask AI
Bookmark
Share

Authors

LLLucy LimCWChun Tao WaiFundación Juan MarchYLY. M. Lee

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lim et al. (2002) studied this question.

synapsesocial.com/papers/6a7b9b253469ba7c45ed14ffhttps://doi.org/10.1046/j.1365-2036.2002.01364.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Lamivudine Is Effective in Suppressing Hepatitis B Virus Dna in Chinese Hepatitis B Surface Antigen Carriers: A Placebo–Controlled Trial1997 · 223 citations
  2. 2A Preliminary Trial of Lamivudine for Chronic Hepatitis B Infection1995 · 810 citations
  3. 3Fatal Reactivation of Chronic Hepatitis B Virus Infection Following Withdrawal of Chemotherapy in Lymphoma Patients1989 · 141 citations
  4. 4Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma2000 · 200 citations